ロード中...
Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA
The FDA Amendments Act (FDAAA) required that information for certain clinical trials, such as details about study design features and endpoints, as well as results, be publicly reported in ClinicalTrials.gov. We conducted a cross-sectional analysis of phase III trials with primary results published...
保存先:
| 出版年: | Trials |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7376878/ https://ncbi.nlm.nih.gov/pubmed/32703252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04603-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|